Details

NameSymbolSector
KWALITY PHARMACEUTICALS LIMITEDKPLPharmaceuticals
Open
3422.05
High
3712.35
Low
3422.05
Close
3669.25
Volume
20704
Exchange
bse
Time
08-Sep-2026

Outlook

Score:

4.75

Rating:

FAIR

Candlestick Pattern

CandlepatternofKwalityPharmaceuticalsis
Opening Marubozu
EstimatedStoplossofKwalityPharmaceuticalsis
3422.05
KwalityPharmaceuticalshasa
Bullishℹ
pattern.
Formationof
Opening Marubozu
candlepatternindicatesKwalityPharmaceuticalshaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

KwalityPharmaceuticalsisin
Uptrendℹ
.
PriceofKwalityPharmaceuticalsis
Upℹ
by

23.97

%.
Target
Buy@

2702.05

Sell@

3708.5

Current@

3669.25

Volume

ThetradesofKwalityPharmaceuticalshavebeenin
Immenseℹ
volume.
ThevolumetradesforKwalityPharmaceuticalsare
Bullishℹ
with
Strong Buyersℹ
ThetradevolumeofKwalityPharmaceuticalsis

Up

by

186.64

%

Valuation

ThecurrentmarketpriceofKwalityPharmaceuticalsis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth447crandtotalassetsworth447cr,thebalancesheetofKwalityPharmaceuticalsis:
Balancedℹ
.
Cashflow
KwalityPharmaceuticalshas
Sufficientℹ
cashflowbecausethereis

Surplus

of

₹ 9cr

.Itis
Upℹ
by

0

%.
55.32% i.e. ₹ 52cr earned in operatingℹ
29.79% i.e. ₹ 28cr spent in investingℹ
14.89% i.e. ₹ 14cr spent in financingℹ
0% in otherℹ
KwalityPharmaceuticalshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Upℹ
by

100

%.
49.41% i.e. ₹ 42cr earned in operatingℹ
30.59% i.e. ₹ 26cr spent in investingℹ
20% i.e. ₹ 17cr spent in financingℹ
0% in otherℹ
Income
TheincomeofKwalityPharmaceuticalsis

₹ 111cr

and

Profit

is:

₹ 14cr

KwalityPharmaceuticalsProfitisupby:

27.27

%andIncomeisUpby:

0

%
TheincomeofKwalityPharmaceuticalsis

₹ 111cr

and

Profit

is:

₹ 11cr

KwalityPharmaceuticalsProfitisdownby:

21.43

%andIncomeisDownby:

4.31

%
TheincomeofKwalityPharmaceuticalsis

₹ 116cr

and

Profit

is:

₹ 14cr

KwalityPharmaceuticalsProfitisupby:

75

%andIncomeisUpby:

36.47

%
By using this site you agree to the use of cookies to deliver a better site experience.